α-Glucosidase-IN-49

α-Glucosidase-IN-49

Cat. No.: DIA-0243019

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
Formula C21H13F3N4O3S3
Molecular Weight 522.54
SMILES O=C(/C(S1)=C/C2=CC=C(C(NC3=NN=C(SCC4=CC=C(C(F)(F)F)C=C4)S3)=O)C=C2)NC1=O
Target Glucosidase
Product Description α-Glucosidase-IN-49 (compound C23) is a potent inhibitor of α-Glucosidase, with IC50 of 0.52 μM. α-Glucosidase-IN-49 has oral bioactivity that can reduce blood glucose and improve glucose tolerance in mice.
Format & Storage
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top